Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54.8M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
30.6M
-
Shares change
-
+664K
-
Total reported value, excl. options
-
$390M
-
Value change
-
+$7.88M
-
Put/Call ratio
-
0.62
-
Number of buys
-
59
-
Number of sells
-
-61
-
Price
-
$12.73
Significant Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2020
179 filings reported holding CARA - Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2020.
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.6M shares
of 54.8M outstanding shares and own 55.86% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.69M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.18M shares), FARALLON CAPITAL MANAGEMENT LLC (2.25M shares), VANGUARD GROUP INC (2.24M shares), FIRST MANHATTAN CO (2.12M shares), Carmignac Gestion (1.91M shares), Chescapmanager LLC (1.31M shares), BANK OF AMERICA CORP /DE/ (1.13M shares), STATE STREET CORP (950K shares), and DISCIPLINED GROWTH INVESTORS INC /MN (733K shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.